- Title:
Block listing Interim Review - Time:
14:30:43 - Date:
14 Apr 2020 - Category:
Capital structure - ID:
6144J
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 14 April 2020
| Name of applicant: |
Hikma Pharmaceuticals PLC |
|||
| Name of scheme: |
Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
|
|||
| Period of return |
From: |
1 October 2019 |
To: |
31 March 2020 |
| Balance of unallotted securities under scheme(s) from previous return: |
SOP: 792,700 ordinary shares of 10 pence |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
SOP: 0 ordinary shares of 10 pence |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
SOP: 0 ordinary shares of 10 pence |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
SOP: 792,700 ordinary shares of 10 pence |
|||
| Name of contact: |
Peter Speirs |
| Telephone number of contact: |
0207 399 2772 |
Block Listing Six Monthly Return
Date: 14 April 2020
| Name of applicant: |
Hikma Pharmaceuticals PLC |
|||
| Name of scheme: |
Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") |
|||
| Period of return |
From: |
1 October 2019 |
To: |
31 March 2020 |
| Balance of unallotted securities under scheme(s) from previous return: |
LTIP: 102,714 ordinary shares of 10 pence
|
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
LTIP: 0 ordinary shares of 10 pence |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
LTIP: 15,014 ordinary shares of 10 pence |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
LTIP: 87,700 ordinary shares of 10 pence |
|||
| Name of contact: |
Peter Speirs |
| Telephone number of contact: |
0207 399 2772 |
Block Listing Six Monthly Return
Date: 14 April 2020
| Name of applicant: |
Hikma Pharmaceuticals PLC |
|||
| Name of scheme: |
Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP") |
|||
| Period of return |
From: |
1 October 2019 |
To: |
31 March 2020 |
| Balance of unallotted securities under scheme(s) from previous return: |
MIP: 770,393 ordinary shares of 10 pence |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
MIP: 1,000,000 ordinary shares of 10 pence |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
MIP: 8,391 ordinary shares of 10 pence |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
MIP: 1,519,989 ordinary shares of 10 pence |
|||
| Name of contact: |
Peter Speirs |
| Telephone number of contact: |
0207 399 2772 |
Block Listing Six Monthly Return
Date: 14 April 2020
| Name of applicant: |
Hikma Pharmaceuticals PLC |
|||
| Name of scheme: |
Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") |
|||
| Period of return |
From: |
1 October 2019 |
To: |
31 March 2020 |
| Balance of unallotted securities under scheme(s) from previous return: |
EIP: 1,541,128 ordinary shares of 10 pence |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
EIP: 0 ordinary shares of 10 pence |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
EIP: 8,742 ordinary shares of 10 pence |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
EIP: 1,102,558 ordinary shares of 10 pence |
|||
| Name of contact: |
Peter Speirs |
| Telephone number of contact: |
0207 399 2772 |
LEI: 549300BNS685UXH4JI75
Block listing Interim Review14:30:4314 Apr 2020Capital structure6144J